Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02324439Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Southern Illinois University. Primary endpoint: Feasibility of consuming 20g of flaxseed per day at 24 months. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02324439.